Until recently, miraculous-healing mega-dose vitamin C could only be delivered through IV, and not orally. Those levels either blow out the bowel tolerance level or get urinated out before they can do their work. But now, you can achieve the results of IV mega-dose vitamin C orally, successfully. It’s called Liposomal vitamin C. Liposomal vitamin C is a lipid encapsulation of ascorbic acid granules that delivers more vitamin C to cells orally than even mega-dose IV vitamin C. At first, vitamin C expert Dr. Thomas Levy found this hard to believe, even as clinical results were being achieved. He investigated further and was impressed. It’s estimated that maybe 20% of IV vitamin C volume gets into cells, while 90% of liposomal C permeates tissue on a cellular level. Vitamin C is water soluble, and cell walls are fatty. Liposomal C is lipid (fatty substance) encapsulated on a molecular level. This enables higher oral doses of vitamin C to permeate cells while not overwhelming bowel tolerance.
If a cardiologist MD with years of experience administering mega-dose vitamin C such as Dr. Levy was impressed, you could be impressed too. Some of you may be familiar with the story of New Zealand dairy farmer Alan Smith, who recovered rapidly from a coma due to flu complicated double pneumonia and leukemia. Many online versions make it seem his recovery was only from IV C. Read: Man with Pneumonia Saved by High Dose Vitamin C But after several legal attempts from Alan’s family to continue administering 50 to 100 grams of IV C after showing positive results when they were ready to pull the plug on his life support, the hospital cynically conceded to continue with only two grams of IV C daily. That’s when his family members found out about a newly produced liposomal C which they brought to Alan daily. Each packet contained one gram of encapsulated vitamin C. Alan consumed six daily and achieved the miraculous results he had experienced with the 50 to 100 grams daily of IV C.
Yes, six grams of liposomal C did the work of 50 to 100 grams of IV C. He walked out of the hospital in days on his own power. A year later, he was examined and there was no trace of leukemia either. Here’s a New Zealand 60 Minutes video clip that covers his story well. Another example of liposomal C’s power: at the Fukushima hot spot, a team of orthomolecular (mega-dose supplement medicine) scientists administered 25 grams of IV C before working and six grams daily of liposomal C to one group of site clean-up workers while giving none to another group. The vitamin C crew came back with no signs of radioactive poisoning while the crew without vitamin C showed high toxicity levels. That radioactive poisoned group was given the same IV and liposomal C treatments as the first group, and they all recovered. This research team’s efforts at communicating their results were suppressed despite their pleas with various Japanese officials. Practitioners who administer mega-dose IV vitamin C are not easy to find, and neither is insurance coverage.
provides a directory of practitioners who deliver mega-dose IV vitamin C. Lypo-Spheric liposomal vitamin C is manufactured by Livon Labs, where you can get great information on how liposomal C works. But you can get it for around $30.00 U.S. for a box of 30 one gram gel packets from other sources. That may be pricey for normal vitamin C intake. But for a serious condition, it’s easier than trying to find a practitioner who can administer IV mega-dose vitamin C, and it’s a lot less expensive. Disclaimer: This story is for educational purposes and should not be construed as medical advice.Dr. Lemmo is considered a leading expert on the use of intravenous vitamin C (i.e. ascorbic acid, ascorbate) and cancer. He has given well over 17,000 infusions of vitamin C-based treatments to people with cancer beginning in 1999. As a consequence, he has pioneered a unique and customized protocol that may differ from other physicians, which Dr. Lemmo has found to optimally help his patients with cancer, live stronger, support and harness the immune system, and improve the quality in their lives.
Dr. Lemmo has discovered that the classic high dose-model of administering vitamin C-based treatments is not typically needed and may in fact be detrimental or harmful for some. Of course there may be some exceptions. Earlier in his career, Dr Lemmo was using doses upwards to 150,000mg or 150 grams of vitamin C in select patients. However, he had also found that higher-dose treatments can place the body in an increased state of stress and actually further exhaust the body over time – more is not necessarily better for every patient or cancer case. It is important to customize the therapy whenever possible. Other physicians who have been using vitamin C-based treatments in people with cancer over time are also noticing a similar trend. Experience can be crucial in this area. Dr. Lemmo’s work has been discussed throughout North America, bringing him to Arizona in February 2012, where he was invited to speak on the subject at the inaugural Naturopathic Oncology Conference.
His ongoing work has begun to influence the model on how intravenous vitamin C-based treatments are used in cancer. Of course, not all would agree with such an approach. While the more standard oncology community feels that such treatments should not be combined with either chemotherapy or radiation, a growing body of data is showing that this recommendation is incorrect.. Dr. Lemmo’s experience demonstrates that a combination approach allows for a “synergistic-effect” to, for example, enhance chemotherapy while at the same time protecting the body (i.e. decrease negative side-effects). Case after case is demonstrating how the effectiveness and tolerance of chemotherapy can be improved when taken together with intravenous vitamin C treatment. Radiation is showing a similar trend, however the data is much more preliminary or experimental. Dr Lemmo believes that the greatest benefit of vitamin C lies in its combination with conventional treatment or other therapies versus using each one on its own.
Those oncologists who are may be considered more open-minded have supported this trend and refer patients to our centre for this approach when needed or when asked. Cancer cells respond very differently to intravenous vitamin C than when compared to the body’s normal cells. For example, a cancer cell makes a rather rapid and sustained increase in hydrogen peroxide in response to vitamin C which results in a “rusting-effect” known as oxidative damage (i.e. this is how some of the more classic chemotherapy agents work to kill cancer along with radiation therapy). Normal or healthy cells do not respond this way with vitamin C. This phenomenon makes intravenous vitamin C a very unique and targeted treatment unlike any other chemotherapy-like medicine. It is important that each intravenous treatment be tailored to the individual patient and particular situation. Protocols are adjusted based on how the patient is feeling, the type of cancer(s), conventional treatments they are receiving, and what is financially feasible over time as well.
Supportive ingredients alongside the vitamin C appears to assist in enhancing the effectiveness of the treatment which includes supporting and harnessing the immune-system (i.e. immuno-oncology). Typically, a person could receive 2-3 treatments per week and the duration depends on how a patient responds and tolerates the treatment. In the beginning, it is advised that a person try a treatment cycle for at least 8 weeks to help assess the potential benefit of treatment. Doses are started low and gradually increased to better customize a person’s individual tolerance. Similar to a treating medical oncologist, there may be a need to adjust or change a treatment protocol at any time. We have many, many protocols to use in cancer care, and the art of medicine is to determine which one(s) works best for you. A 2010 study evaluating the use of vitamin C amongst practitioners revealed, after calculating over 750,000 yearly sales and estimated yearly doses of over 350,000 in 2008, and after evaluating over 9000 patients, only minor side-effects were noted that included lethargy/fatigue, change in mental status, and vein irriation.